VRTXVertex Pharmaceuticals Incorporated
NAS · US · Healthcare · Biotechnology · vrtx.com
550.36USD-0.31%Mkt Cap: 139.84B $P/E: 32.15

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on spec…

Key Statistics

Company
Market Cap139.84B $
Enterprise Value131.06B $
Revenue (TTM)12.59B $
Gross Profit10.35B $
Net Income (TTM)3.95B $
Revenue/Share49.51 USD
Last Price550.36 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6.4K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)32.15
P/E (Forward)24.73
PEG1.91
EV/EBITDA25.70
EV/Revenue10.41
P/S10.88
P/B6.76
EPS (TTM)16.80
EPS (Forward)21.84
52W Range
374.1798% of range553.69
52W High553.69 USD
52W Low374.17 USD
Profitability
Gross Margin86.24%
Oper. Margin38.05%
EBITDA Margin40.52%
Profit Margin32.94%
ROE21.18%
ROA15.42%
Growth
Revenue Growth12.50%
Earnings Growth8.00%
Cash Flow & Leverage
Operating CF3.63B $
CapEx (TTM)437.60M $
FCF Margin20.88%
FCF Yield1.88%
Net Debt-5.87B $
Net Debt/EBITDA-1.15
Balance Sheet
Debt/Equity0.11
Current Ratio3.19
Quick Ratio2.54
Book Value/Sh79.92 USD
Cash/Share30.98 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split2:1
Split DateAug 24, 2000
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)563.12 USD
Upside (mean)+2.3%
Target Range350.00 USD672.00 USD
$350.00+2.3% to mean$672.00
# Analysts25
Ownership
Shares Out.253.30M
Float252.68M
Insiders0.21%
Institutions98.13%
Short Interest
Short Ratio2.7d
Short % Float1.76%
Short % Out.1.56%
Shares Short3.94M
Short (prev mo.)4.94M
Technical
SMA 50488.61 (+12.6%)
SMA 200459.36 (+19.8%)
Beta0.30
S&P 52W Chg18.16%
Avg Vol (30d)1.31M
Avg Vol (10d)1.29M
Technical Indicators
RSI (14)70.9
MACD13.2392
MACD Signal8.7886
MACD Hist.+4.4506
BB Upper542.92 USD
BB Middle495.90 USD
BB Lower448.88 USD
BB Width18.96%
ATR (14)16.99 USD
Vol Ratio (20d)1.15x